Is the NefIgArd trial a paradigm shift in the treatment of IgA nephropathy? Gutierrez E, Caravaca-Fontan F, Sevillano A. Kidney Int 2023;103:994.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gutierrez E, Caravaca-Fontan F, Sevillano A. Is the NefIgArd trial a paradigm shift in the treatment of IgA nephropathy? Kidney Int 2023;103:994.
PMID: 37085261